首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Investigation of surface and drug release of solid lipid nanoparticles loaded with aciclovir
【24h】

Investigation of surface and drug release of solid lipid nanoparticles loaded with aciclovir

机译:载有阿昔洛韦的固体脂质纳米粒的表面和药物释放研究

获取原文

摘要

Solid lipid nanoparticles (SLN) are a particulate carrier system alternative to polymer nanoparticles or liposomes. SLN have the advantage of biodegradability, low toxicity and low costs in production. They consist of physiological biocompatible lipids, which are suitable for the incorporation of lipophilic, hydrophilic and poorly water soluble active ingredients. Limited data are reported about structure, particle order and crystallinity of loaded and unloaded SLN. The physical structure influences stability, amount of incorporated drugs and drug release. The aim of this study is the incorporation of the model drug aciclovir in SLN and the determination of its influence on the properties of the matrix. This shall be investigaged by transmission electron microscopy (TEM), atomic force microscopy (AFM) and small angle X-ray scattering(SAXS).
机译:固体脂质纳米颗粒(SLN)是可替代聚合物纳米颗粒或脂质体的颗粒载体系统。 SLN具有可生物降解,低毒性和生产成本低的优点。它们由生理生物相容性脂质组成,适用于掺入亲脂性,亲水性和水溶性差的活性成分。关于装载和卸载的SLN的结构,颗粒顺序和结晶度的报道有限。物理结构影响稳定性,掺入的药物量和药物释放。这项研究的目的是将模型药物阿昔洛韦纳入SLN中,并确定其对基质性质的影响。应通过透射电子显微镜(TEM),原子力显微镜(AFM)和小角度X射线散射(SAXS)进行调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号